Clinical Trial Update: Quality of Life and Medical Care of Long-term Sarcoma Survivors in Germany (PROSa+)

View source ↗

Summary

PROSa+ is a German clinical study assessing quality of life and medical care needs among long-term sarcoma survivors. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Snippet

Sponsor: Technische Universität Dresden | Conditions: Sarcoma, Survivorship | Status: RECRUITING